Published in PLoS One on August 24, 2009
ppGpp conjures bacterial virulence. Microbiol Mol Biol Rev (2010) 1.97
ppGpp: magic beyond RNA polymerase. Nat Rev Microbiol (2012) 1.91
Characterization of the RelBbu regulon in borrelia burgdorferi reveals modulation of glycerol metabolism by (p)ppGpp. PLoS One (2015) 1.45
Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague. Infect Immun (2010) 0.98
A live attenuated strain of Yersinia pestis KIM as a vaccine against plague. Vaccine (2011) 0.88
Coregulation of host-adapted metabolism and virulence by pathogenic yersiniae. Front Cell Infect Microbiol (2014) 0.85
A framework for analysis of abortive colony size distributions using a model of branching processes in irradiated normal human fibroblasts. PLoS One (2013) 0.83
Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity. Infect Immun (2012) 0.83
Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis. Microb Pathog (2012) 0.82
Developing live vaccines against plague. J Infect Dev Ctries (2011) 0.81
Ribosome•RelA structures reveal the mechanism of stringent response activation. Elife (2016) 0.81
LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague. Infect Immun (2014) 0.79
relA enhances the adherence of enteropathogenic Escherichia coli. PLoS One (2014) 0.79
Bacterial Stress Responses during Host Infection. Cell Host Microbe (2016) 0.78
Pathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A. Infect Immun (2013) 0.78
Ralstonia solanacearum ΔPGI-1 strain KZR-5 is affected in growth, response to cold stress and invasion of tomato. Microb Ecol (2010) 0.77
A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypes. Infect Immun (2014) 0.77
Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague. Vaccine (2015) 0.76
Plague: Infections of Companion Animals and Opportunities for Intervention. Animals (Basel) (2011) 0.75
Environmental Regulation of Yersinia Pathophysiology. Front Cell Infect Microbiol (2016) 0.75
Selective Protective Potency of Yersinia pestis ΔnlpD Mutants. Acta Naturae (2015) 0.75
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
The complete genome sequence of Escherichia coli K-12. Science (1997) 84.27
Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol (1951) 28.27
Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature (2001) 16.89
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Genome sequence of Yersinia pestis KIM. J Bacteriol (2002) 7.14
Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun (1986) 6.92
Residual guanosine 3',5'-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations. J Biol Chem (1991) 6.66
Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect Immun (1984) 6.63
Studies on the nutrition and physiology of Pasteurella pestis. III. Effects of calcium ions on the growth of virulent and avirulent strains of Pasteurella pestis. J Bacteriol (1959) 6.55
The genus Yersinia: biochemistry and genetics of virulence. Curr Top Microbiol Immunol (1972) 6.32
Plasmids in Yersinia pestis. Infect Immun (1981) 6.22
(p)ppGpp: still magical? Annu Rev Microbiol (2008) 5.88
Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol (1994) 5.82
The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev (1998) 5.78
Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol (1989) 5.39
Secretion of Yop proteins by Yersiniae. Infect Immun (1990) 4.64
Factors promoting acute and chronic diseases caused by yersiniae. Clin Microbiol Rev (1991) 4.53
Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol (2005) 4.46
A surface protease and the invasive character of plague. Science (1992) 4.44
Herpesvirus latency confers symbiotic protection from bacterial infection. Nature (2007) 4.27
In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae. Infect Immun (1984) 4.16
The HD domain defines a new superfamily of metal-dependent phosphohydrolases. Trends Biochem Sci (1998) 4.11
Epitope tagging of chromosomal genes in Salmonella. Proc Natl Acad Sci U S A (2001) 4.01
Pasteurella pestis: Role of Pesticin I and Iron in Experimental Plague. Science (1965) 3.90
Evolution of aminoacyl-tRNA synthetases--analysis of unique domain architectures and phylogenetic trees reveals a complex history of horizontal gene transfer events. Genome Res (1999) 3.44
Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun (1993) 3.16
Cell-surface-bound Yersinia translocate the protein tyrosine phosphatase YopH by a polarized mechanism into the target cell. Mol Microbiol (1995) 3.06
Amino acid requirements of Legionella pneumophila. J Clin Microbiol (1980) 2.88
The stringent response of Mycobacterium tuberculosis is required for long-term survival. J Bacteriol (2000) 2.80
A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science (2007) 2.69
The nucleotide sequence and characterization of the relA gene of Escherichia coli. J Biol Chem (1988) 2.45
TH1-TH2: a procrustean paradigm. Nat Immunol (2003) 2.44
Co-ordination of legionella pneumophila virulence with entry into stationary phase by ppGpp. Mol Microbiol (1999) 2.38
Effect of exogenous nucleotides on Ca2+ dependence and V antigen synthesis in Yersinia pestis. Infect Immun (1982) 2.32
Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci U S A (2006) 2.31
DNA sequencing and analysis of the low-Ca2+-response plasmid pCD1 of Yersinia pestis KIM5. Infect Immun (1998) 2.26
Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun (1994) 2.26
Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun (2003) 2.20
Plasminogen activator/coagulase gene of Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins. Infect Immun (1988) 2.15
The ACT domain family. Curr Opin Struct Biol (2001) 1.86
Identification of Legionella pneumophila mutants that have aberrant intracellular fates. Infect Immun (1996) 1.84
Acyl carrier protein/SpoT interaction, the switch linking SpoT-dependent stress response to fatty acid metabolism. Mol Microbiol (2006) 1.82
The Legionella pneumophila rpoS gene is required for growth within Acanthamoeba castellanii. J Bacteriol (1999) 1.76
Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines (2008) 1.71
Mutational analysis of the Escherichia coli spoT gene identifies distinct but overlapping regions involved in ppGpp synthesis and degradation. Mol Microbiol (1996) 1.70
Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun (2005) 1.68
Characterization of the spoT gene of Escherichia coli. J Biol Chem (1989) 1.67
Comparative genomics and evolution of genes encoding bacterial (p)ppGpp synthetases/hydrolases (the Rel, RelA and SpoT proteins). J Mol Microbiol Biotechnol (2001) 1.66
Characterization of the Yersinia pestis Yfu ABC inorganic iron transport system. Infect Immun (2001) 1.65
LcrV plague vaccine with altered immunomodulatory properties. Infect Immun (2005) 1.57
Invasion of epithelial cells by Yersinia pestis: evidence for a Y. pestis-specific invasin. Infect Immun (2000) 1.56
Salmonella redirects phagosomal maturation. Curr Opin Microbiol (2004) 1.48
Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection. Infect Immun (2006) 1.47
Effect of Ca2+ on morphology and division of Yersinia pestis. Infect Immun (1974) 1.46
Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect Immun (1997) 1.45
Listeria monocytogenes relA and hpt mutants are impaired in surface-attached growth and virulence. J Bacteriol (2002) 1.45
Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci U S A (2008) 1.43
ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem (2004) 1.41
Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin Vaccine Immunol (2007) 1.37
Characterization of a Legionella pneumophila relA insertion mutant and toles of RelA and RpoS in virulence gene expression. J Bacteriol (2002) 1.35
Pseudomonas aeruginosa relA contributes to virulence in Drosophila melanogaster. Infect Immun (2004) 1.32
The bacterial signal molecule, ppGpp, regulates Salmonella virulence gene expression. Mol Microbiol (2004) 1.28
Murine toxin of Yersinia pestis shows phospholipase D activity but is not required for virulence in mice. Int J Med Microbiol (2000) 1.28
Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol (2007) 1.21
RNA synthesis in Yersinia pestis during growth restriction in calcium-deficient medium. J Bacteriol (1982) 1.21
The Pla surface protease/adhesin of Yersinia pestis mediates bacterial invasion into human endothelial cells. FEBS Lett (2001) 1.21
Mutation in the relA gene of Vibrio cholerae affects in vitro and in vivo expression of virulence factors. J Bacteriol (2003) 1.15
The bacterial signal molecule, ppGpp, mediates the environmental regulation of both the invasion and intracellular virulence gene programs of Salmonella. J Biol Chem (2006) 1.14
Expression of the low calcium response in Yersinia pestis. Microb Pathog (1989) 1.13
Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates. Microb Pathog (2006) 1.11
Highly efficient method for introducing successive multiple scarless gene deletions and markerless gene insertions into the Yersinia pestis chromosome. Appl Environ Microbiol (2008) 1.11
Global gene expression during stringent response in Corynebacterium glutamicum in presence and absence of the rel gene encoding (p)ppGpp synthase. BMC Genomics (2006) 1.11
The YopD translocator of Yersinia pseudotuberculosis is a multifunctional protein comprised of discrete domains. J Bacteriol (2004) 1.10
Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine. Clin Vaccine Immunol (2007) 1.06
Antibodies and cytokines independently protect against pneumonic plague. Vaccine (2008) 1.06
Proteomic characterization of Yersinia pestis virulence. J Bacteriol (2005) 1.04
Comparison of DeltarelA strains of Escherichia coli and Salmonella enterica serovar Typhimurium suggests a role for ppGpp in attenuation regulation of branched-chain amino acid biosynthesis. J Bacteriol (2001) 0.99
Using every trick in the book: the Pla surface protease of Yersinia pestis. Adv Exp Med Biol (2007) 0.98
Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN-gamma: effect of dose and formulation. Vaccine (1998) 0.79
Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science (2010) 3.53
Fatty acid production in genetically modified cyanobacteria. Proc Natl Acad Sci U S A (2011) 2.77
Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine. Infect Immun (2002) 2.25
Identification of pathogen-specific and conserved genes expressed in vivo by an avian pathogenic Escherichia coli strain. Proc Natl Acad Sci U S A (2002) 2.12
NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8⁺ T cells. Nat Immunol (2012) 1.62
Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol Med Microbiol (2003) 1.56
Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates. Hum Vaccin Immunother (2012) 1.46
Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci U S A (2008) 1.43
Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci U S A (2008) 1.43
Sequencing and functional annotation of avian pathogenic Escherichia coli serogroup O78 strains reveal the evolution of E. coli lineages pathogenic for poultry via distinct mechanisms. Infect Immun (2012) 1.37
Role of virulence factors in resistance of avian pathogenic Escherichia coli to serum and in pathogenicity. Infect Immun (2003) 1.36
Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium. Infect Immun (2011) 1.30
Recombinant attenuated Salmonella enterica serovar typhimurium expressing the carboxy-terminal domain of alpha toxin from Clostridium perfringens induces protective responses against necrotic enteritis in chickens. Clin Vaccine Immunol (2008) 1.23
Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun (2008) 1.23
Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect Immun (2002) 1.18
Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors. J Bacteriol (2002) 1.17
Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J Immunol (2011) 1.15
Contribution of the SitABCD, MntH, and FeoB metal transporters to the virulence of avian pathogenic Escherichia coli O78 strain chi7122. Infect Immun (2007) 1.14
Nickel-inducible lysis system in Synechocystis sp. PCC 6803. Proc Natl Acad Sci U S A (2009) 1.13
A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect Immun (2006) 1.12
A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Infect Immun (2008) 1.12
Highly efficient method for introducing successive multiple scarless gene deletions and markerless gene insertions into the Yersinia pestis chromosome. Appl Environ Microbiol (2008) 1.11
SdiA, an N-acylhomoserine lactone receptor, becomes active during the transit of Salmonella enterica through the gastrointestinal tract of turtles. PLoS One (2008) 1.11
The introduction of new vaccines into developing countries. IV: Global Access Strategies. Vaccine (2007) 1.11
Inactivation of the pst system reduces the virulence of an avian pathogenic Escherichia coli O78 strain. Infect Immun (2005) 1.09
PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae. Infect Immun (2009) 1.09
Full sequence and comparative analysis of the plasmid pAPEC-1 of avian pathogenic E. coli chi7122 (O78:K80:H9). PLoS One (2009) 1.07
CO2-limitation-inducible Green Recovery of fatty acids from cyanobacterial biomass. Proc Natl Acad Sci U S A (2011) 1.07
Role of avian pathogenic Escherichia coli virulence factors in bacterial interaction with chicken heterophils and macrophages. Infect Immun (2003) 1.07
Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen. PLoS One (2010) 1.04
Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice. Clin Vaccine Immunol (2010) 1.04
Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect Immun (2010) 1.04
Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium. J Bacteriol (2008) 1.03
The Salmonella Pathogenicity Island (SPI) 1 contributes more than SPI2 to the colonization of the chicken by Salmonella enterica serovar Typhimurium. BMC Microbiol (2009) 1.03
Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect Immun (2010) 1.02
Contribution of Thy1+ NK cells to protective IFN-γ production during Salmonella typhimurium infections. Proc Natl Acad Sci U S A (2013) 1.02
Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi. Infect Immun (2006) 1.02
Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infect Immun (2008) 1.01
Characterization of the contribution to virulence of three large plasmids of avian pathogenic Escherichia coli chi7122 (O78:K80:H9). Infect Immun (2010) 0.99
Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen. Infect Immun (2009) 0.98
Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague. Infect Immun (2010) 0.98
Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model. Vaccine (2011) 0.98
Selective capture of Salmonella enterica serovar typhi genes expressed in macrophages that are absent from the Salmonella enterica serovar Typhimurium genome. Infect Immun (2005) 0.97
Construction of transcriptional and translational lacZ gene reporter plasmids for use in Streptococcus mutans. J Microbiol Methods (2002) 0.96
Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers. Clin Vaccine Immunol (2010) 0.96
New insights into the bacterial fitness-associated mechanisms revealed by the characterization of large plasmids of an avian pathogenic E. coli. PLoS One (2012) 0.95
New technologies in developing recombinant attenuated Salmonella vaccine vectors. Microb Pathog (2012) 0.95
Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Vaccine (2010) 0.94
Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines. Infect Immun (2010) 0.94
Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. Adv Exp Med Biol (2007) 0.94
A dual-signal regulatory circuit activates transcription of a set of divergent operons in Salmonella typhimurium. Proc Natl Acad Sci U S A (2008) 0.93
Turning self-destructing Salmonella into a universal DNA vaccine delivery platform. Proc Natl Acad Sci U S A (2012) 0.93
The Campylobacter jejuni Dps homologue is important for in vitro biofilm formation and cecal colonization of poultry and may serve as a protective antigen for vaccination. Clin Vaccine Immunol (2012) 0.92
Comparative genome analysis of the high pathogenicity Salmonella Typhimurium strain UK-1. PLoS One (2012) 0.92
Phosphate groups of lipid A are essential for Salmonella enterica serovar Typhimurium virulence and affect innate and adaptive immunity. Infect Immun (2012) 0.91
Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge. Vaccine (2010) 0.91
Export of extracellular polysaccharides modulates adherence of the Cyanobacterium synechocystis. PLoS One (2013) 0.90
Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine. Infect Immun (2010) 0.89
Thermorecovery of cyanobacterial fatty acids at elevated temperatures. J Biotechnol (2012) 0.89
Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium. Infect Immun (2004) 0.89
A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine. J Virol (2009) 0.88
Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. Vaccine (2011) 0.88
The aspartate-semialdehyde dehydrogenase of Edwardsiella ictaluri and its use as balanced-lethal system in fish vaccinology. PLoS One (2010) 0.88
A live attenuated strain of Yersinia pestis KIM as a vaccine against plague. Vaccine (2011) 0.88
Complete genome sequence of the universal killer Salmonella enterica Serovar Typhimurium UK-1 (ATCC 68169). J Bacteriol (2011) 0.87
Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype. Vaccine (2010) 0.87
Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice. Infect Immun (2010) 0.87
Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant. Infect Immun (2011) 0.85
Differential effect of auxotrophies on the release of macromolecules by Salmonella enterica vaccine strains. FEMS Microbiol Lett (2006) 0.85
A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA. Vaccine (2013) 0.85
Modulation of the regulatory activity of bacterial two-component systems by SlyA. J Biol Chem (2008) 0.84
Mechanisms of intrinsic resistance to antimicrobial peptides of Edwardsiella ictaluri and its influence on fish gut inflammation and virulence. Microbiology (2013) 0.84